DR. KETAN DESAI, MD PHD
Osteopathic Medicine at Spring Rd, Easton, PA
License number
Pennsylvania K0018
Category
Osteopathic Medicine
Type
Allergy & Immunology
License number
Pennsylvania K0018
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Pennsylvania K0018
Category
Osteopathic Medicine
Type
Rheumatology
Address
Address
1175 Spring Rd, Easton, PA 18040
Phone
(610) 252-8240
Personal information
See more information about KETAN DESAI at radaris.comName
Address
Phone
1175 Spring Rd, Easton, PA 18040
1801 Buttonwood St, Philadelphia, PA 19130
1250 Collegeville Rd, Collegeville, PA 19426
1175 Spring Rd, Forks, PA 18040
105 Nottingham Dr, Spring City, PA 19475
Professional information
See more information about KETAN DESAI at trustoria.com
Co-Administration Of Steroids And Zoledronic Acid To Prevent And Treat Side Effects From Zoledronic Acid Infusion
Co-Administration Of Steroids And Zoledronic Acid To Prevent And Treat Side Effects From Zoledronic Acid Infusion
US Patent:
2011026, Oct 27, 2011
Filed:
Apr 26, 2010
Appl. No.:
12/767387
Inventors:
Ketan Desai - Easton PA, US
International Classification:
A61K 31/675
US Classification:
514 94
Abstract:
Zoledronic Acid is used for treatment of hypercalcemia of malignancy, for the treatment of bone metastasis associated with malignancies such as prostate and breast cancer, for the prevention of and treatment of osteoporosis and for the treatment of Paget's disease. Administration of Zoledronic Acid is complicated by what is described as “post-dosing syndrome” (PDS) and osteonecrosis of the jaw (ONJ). Inflammation may be the cause of these side effects, which could be decreased by the co-administration of steroids. This application is a method of use patent for the co-administration of steroids (oral, IV, IM, rectal, or by inhalation) with Zoledronic Acid and a composition of matter patent for mixing Methyl Prednisolone with Zoledronic Acid for infusion.
Curcumin Cyclodextrin Combination For Preventing Or Treating Various Diseases
Curcumin Cyclodextrin Combination For Preventing Or Treating Various Diseases
US Patent:
2010017, Jul 15, 2010
Filed:
Jun 22, 2009
Appl. No.:
12/488781
Inventors:
Ketan Desai - Easton PA, US
International Classification:
A61K 47/48, C08B 37/16, A61P 25/00, A61P 25/28, A61P 29/00, A61P 37/08, A61P 11/06, A61P 35/00, A61P 11/00, A61P 17/00, A61P 9/00, A61P 3/06, A61P 1/00
US Classification:
514 58, 536103
Abstract:
Curcumin has shown anti-inflammatory and anti-angiogenic properties that could be useful in treating various diseases such as those of rheumatology and oncology. However, curcumin is very poorly absorbed and has a very low bioavailability. This patent describes a method of increasing the delivery of curcumin by complexing it with cyclodextrins. Cyclodextrins are well known in the food industry and have been used to carry other drugs to increase bioavailability. The new combination of cyclodextrins and curcumin has been tested in pre-clinical inflammation models where it has demonstrated efficacy superior to both the positive control and curcumin.
Emu Oil In Combination With Other Active Ingredients For Treating Skin Imperfections
Emu Oil In Combination With Other Active Ingredients For Treating Skin Imperfections
US Patent:
2012031, Dec 13, 2012
Filed:
Jun 8, 2011
Appl. No.:
13/156308
Inventors:
Scott Alan Weisenfluh - Taylor PA, US
Ketan Desai - Easton PA, US
Sandra Kroposky - Moosic PA, US
Ketan Desai - Easton PA, US
Sandra Kroposky - Moosic PA, US
International Classification:
A61K 35/12, A61Q 7/00, A61P 17/00, A61P 17/18, A61Q 19/08, A61Q 19/02, A61K 8/98, A61P 17/02, A61P 17/10, A61P 17/06
US Classification:
424 62, 424522
Abstract:
Compositions comprising emu oil as a vehicle for the delivery of other active ingredients for the treatment of cosmetic and other skin imperfections such as acne, wrinkles, and hair loss are disclosed. Methods of treating cosmetic and other skin imperfections using the compositions are also disclosed.
Small Molecules For Inhibition Of Protein Kinases
Small Molecules For Inhibition Of Protein Kinases
US Patent:
8389525, Mar 5, 2013
Filed:
May 5, 2010
Appl. No.:
12/774230
Inventors:
Renee Desai - Easton PA, US
Ketan Desai - Easton PA, US
Ketan Desai - Easton PA, US
International Classification:
A61K 31/498, A61K 31/4418, C07D 213/85
US Classification:
514250, 546288, 514344
Abstract:
The invention provides compounds that inhibit protein kinases, prodrugs of the compounds, intermediates and methods of synthesizing the compounds and/or prodrugs, pharmaceutical compositions including the compounds and/or prodrugs and methods of using the compounds and/or prodrugs in a variety of contexts, including, for example, in the treatment and/or prevention of various diseases that are responsive to protein kinase inhibition and/or that are mediated, at least in part, by inappropriate kinase activity.
Small Molecule Inhibitors Of Protein Kinases
Small Molecule Inhibitors Of Protein Kinases
US Patent:
2013005, Mar 7, 2013
Filed:
Nov 2, 2010
Appl. No.:
13/696205
Inventors:
Ketan Desai - Easton PA, US
Renee Desai - Easton PA, US
Renee Desai - Easton PA, US
International Classification:
C07D 495/04, C12N 9/99, A61P 37/06, A61P 35/00, A61P 1/16, A61P 1/18, A61P 11/00, A61P 1/00, A61P 19/10, A61P 37/08, A61P 9/00, A61P 11/06, A61P 17/02, C12N 5/071, A61K 31/519
US Classification:
4242781, 544278, 5142601, 435184, 435375, 435366
Abstract:
Compounds that modulate, for example, that inhibit, syk kinase, and, optionally other kinases. The compounds can be used to treat a variety of disorders, including inflammatory disorders and autoimmune disorders.